Position in ZTS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,154,797
-$2,970,608 QoQ
Shares Held
43,902
-15.3% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#414
of 1,408 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sanctuary Advisors, LLC holds $25,944,542 across 16 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
272,749 | $4,331,254 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
105,645 | $3,662,712 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
18,927 | $3,189,956 | |
| 4 | HLN |
Haleon plc
|
340,028 | $3,172,461 | |
| 5 | ZTS |
Zoetis Inc.
This page
|
43,902 | $3,154,797 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
74,865 | $2,536,426 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
13,756 | $1,138,721 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
1,695 | $918,401 |
All Filings in ZTS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,154,797 | 43,902 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,125,405 | 51,818 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $6,040,492 | 48,009 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $20,780,073 | 142,018 | Shares | Sole | 2026-01-06 | |
| 2025-06-30 | $10,937,709 | 70,136 | Shares | Sole | 2026-01-06 | |
| 2025-03-31 | $11,835,371 | 71,882 | Shares | Sole | 2026-01-06 | |
| 2024-12-31 | $17,301,373 | 106,189 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $20,567,847 | 105,271 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $21,366,099 | 123,247 | Shares | Sole | 2024-09-05 | |
| No filing history on record for this holder in this stock. | ||||||